REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 18th, 2003 • Antares Pharma Inc • Surgical & medical instruments & apparatus • Delaware
This Registration Rights Agreement (the “Agreement”) is made and entered into as of this 12th day of September, 2003 by and among Antares Pharma, Inc. a Minnesota corporation (the “Company”), and Eli Lilly and Company, an Indiana corporation (the “Holder”).
CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. ANTARES PHARMA, INC. AND ELI LILLY AND COMPANY DEVELOPMENT AND LICENSE AGREEMENT...Development and License Agreement • September 18th, 2003 • Antares Pharma Inc • Surgical & medical instruments & apparatus • New York
This Development and License Agreement (“Agreement”) is made and entered into as of the 12th day of September, 2003 (the “Effective Date”) by and between Antares Pharma, Inc., a Minnesota corporation, having its principal place of business at 707 Eagleview Blvd., Suite 414, Exton, Pennsylvania 19341 (“Antares”) and Eli Lilly and Company, an Indiana corporation, having its principal place of business at Lilly Corporate Center, Indianapolis, Indiana 46285 (“Lilly”). Antares and Lilly are sometimes referred to herein individually as a “Party” and collectively as the “Parties”, and references to “Antares” and “Lilly” shall include their respective Affiliates.
Warrant Agreement Warrant to Eli Lilly and Company for the Purchase of Shares of Common Stock of Antares Pharma, Inc., $.01 par value per ShareWarrant Agreement • September 18th, 2003 • Antares Pharma Inc • Surgical & medical instruments & apparatus
Between Antares Pharma, Inc. (the “Company”), a Minnesota corporation, with its principal place of business at 707 Eagleview Boulevard, Suite 414, Exton, Pennsylvania 19341, and Eli Lilly and Company (“the Holder”), an Indiana corporation, with its principal place of business at Lilly Corporate Center, Indianapolis, Indiana, 46285.
